Here Ya Go Muroc, all! I did screw up with our new regime (since June), last Board presented the timeline dates in Fiscal Year entries. In that, today's last day of the first half of FY 22. Got straightened out on that over the phone, and the following e-mails between me and Investor Relations.[/quote]Good Day Lisa, Jon!
Any information about current status or insight into our relationship with Sarcoma Oncology Research Center, LLC (Sponsor) and collaboration with Joseph Ahmed Foundation is appreciated.
No Trial updates since April on this. Here's a link to the Clinical Trial records on this.
Thank You. Very Respectfully ***************************************************************
Investor Relations Sep 30, 2021, 4:20 PM (1 day ago) to me, Lisa
Hello Mike,
Lisa might have responded, but it is not really accurate that there have been no updates on this.
In June we presented interim data from this trial at ASCO (link). -->
Also in June, as part of our strategic overview, we highlighted this as an area of continued focus for us. I believe we said the trial had enrolled 16 of the 24 patients, and we guided for completion of enrollment by 1H next year. (link)
Given that sarcoma is a pretty rare cancer, and this trial is really out of the one site, the enrollment is not bad. This site normally has patients travel from across the US, but this was obviously reduced during COVID. Based on what we know today, we believe our guidance for completing enrollment is achievable.